135 related articles for article (PubMed ID: 30028904)
1. Cancer phenotype in myotonic dystrophy patients: Results from a meta-analysis.
Emparanza JI; López de Munain A; Greene MH; Matheu A; Fernández-Torrón R; Gadalla SM
Muscle Nerve; 2018 Oct; 58(4):517-522. PubMed ID: 30028904
[TBL] [Abstract][Full Text] [Related]
2. Increased cancer risks in myotonic dystrophy.
Win AK; Perattur PG; Pulido JS; Pulido CM; Lindor NM
Mayo Clin Proc; 2012 Feb; 87(2):130-5. PubMed ID: 22237010
[TBL] [Abstract][Full Text] [Related]
3. A population-based survey of risk for cancer in individuals diagnosed with myotonic dystrophy.
Abbott D; Johnson NE; Cannon-Albright LA
Muscle Nerve; 2016 Oct; 54(4):783-5. PubMed ID: 27064430
[TBL] [Abstract][Full Text] [Related]
4. Pigmentation phenotype, photosensitivity and skin neoplasms in patients with myotonic dystrophy.
Gadalla SM; Hilbert JE; Martens WB; Givens S; Moxley RT; Greene MH
Eur J Neurol; 2017 May; 24(5):713-718. PubMed ID: 28317292
[TBL] [Abstract][Full Text] [Related]
5. Cancer risk among patients with myotonic muscular dystrophy.
Gadalla SM; Lund M; Pfeiffer RM; Gørtz S; Mueller CM; Moxley RT; Kristinsson SY; Björkholm M; Shebl FM; Hilbert JE; Landgren O; Wohlfahrt J; Melbye M; Greene MH
JAMA; 2011 Dec; 306(22):2480-6. PubMed ID: 22166607
[TBL] [Abstract][Full Text] [Related]
6. Hypothesis: neoplasms in myotonic dystrophy.
Mueller CM; Hilbert JE; Martens W; Thornton CA; Moxley RT; Greene MH
Cancer Causes Control; 2009 Dec; 20(10):2009-20. PubMed ID: 19642006
[TBL] [Abstract][Full Text] [Related]
7. Brain tumors in patients with myotonic dystrophy: a population-based study.
Gadalla SM; Pfeiffer RM; Kristinsson SY; Björkholm M; Landgren O; Greene MH
Eur J Neurol; 2016 Mar; 23(3):542-7. PubMed ID: 26508558
[TBL] [Abstract][Full Text] [Related]
8. Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink.
Wang Y; Pfeiffer RM; Alsaggaf R; Meeraus W; Gage JC; Anderson LA; Bremer RC; Nikolenko N; Lochmuller H; Greene MH; Gadalla SM
Int J Cancer; 2018 Mar; 142(6):1174-1181. PubMed ID: 29114849
[TBL] [Abstract][Full Text] [Related]
9. Benign and malignant tumors in the UK myotonic dystrophy patient registry.
Alsaggaf R; Wang Y; Marini-Bettolo C; Wood L; Nikolenko N; Lochmüller H; Greene MH; Gadalla SM
Muscle Nerve; 2018 Feb; 57(2):316-320. PubMed ID: 28662292
[TBL] [Abstract][Full Text] [Related]
10. Risk of cancer in relatives of patients with myotonic dystrophy: a population-based cohort study.
Lund M; Diaz LJ; Gørtz S; Feenstra B; Duno M; Juncker I; Eiberg H; Vissing J; Wohlfahrt J; Melbye M
Eur J Neurol; 2014 Sep; 21(9):1192-7. PubMed ID: 24838088
[TBL] [Abstract][Full Text] [Related]
11. Global Prevalence of Myotonic Dystrophy: An Updated Systematic Review and Meta-Analysis.
Liao Q; Zhang Y; He J; Huang K
Neuroepidemiology; 2022; 56(3):163-173. PubMed ID: 35483324
[TBL] [Abstract][Full Text] [Related]
12. Dysplastic nevi, cutaneous melanoma, and other skin neoplasms in patients with myotonic dystrophy type 1: a cross-sectional study.
Zampetti A; Silvestri G; Manco S; Khamis K; Masciullo M; Bianchi ML; Damiani A; Santoro M; Linder D; Bewley A; Feliciani C
J Am Acad Dermatol; 2015 Jan; 72(1):85-91. PubMed ID: 25440959
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
Leu M; Reilly M; Czene K
J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
[TBL] [Abstract][Full Text] [Related]
14. Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Denmark, 1943-80.
Osterlind A; Olsen JH; Lynge E; Ewertz M
Natl Cancer Inst Monogr; 1985 Dec; 68():361-88. PubMed ID: 4088310
[TBL] [Abstract][Full Text] [Related]
15. Cancer risk in women with 10 or more deliveries.
Högnäs E; Kauppila A; Pukkala E; Tapanainen JS
Obstet Gynecol; 2014 Apr; 123(4):811-6. PubMed ID: 24785609
[TBL] [Abstract][Full Text] [Related]
16. Cardiac involvement in myotonic dystrophy: a nationwide cohort study.
Lund M; Diaz LJ; Ranthe MF; Petri H; Duno M; Juncker I; Eiberg H; Vissing J; Bundgaard H; Wohlfahrt J; Melbye M
Eur Heart J; 2014 Aug; 35(32):2158-64. PubMed ID: 24742887
[TBL] [Abstract][Full Text] [Related]
17. Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935-82.
Tucker MA; Boice JD; Hoffman DA
Natl Cancer Inst Monogr; 1985 Dec; 68():161-89. PubMed ID: 4088297
[TBL] [Abstract][Full Text] [Related]
18. Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation.
Fernández-Torrón R; García-Puga M; Emparanza JI; Maneiro M; Cobo AM; Poza JJ; Espinal JB; Zulaica M; Ruiz I; Martorell L; Otaegui D; Matheu A; López de Munain A
Neurology; 2016 Sep; 87(12):1250-7. PubMed ID: 27558368
[TBL] [Abstract][Full Text] [Related]
19. Cancer risks in first-generation immigrants to Sweden.
Hemminki K; Li X; Czene K
Int J Cancer; 2002 May; 99(2):218-28. PubMed ID: 11979437
[TBL] [Abstract][Full Text] [Related]
20. Melanoma, thyroid cancer, and gynecologic cancers in a cohort of female flight attendants.
Pinkerton LE; Hein MJ; Anderson JL; Christianson A; Little MP; Sigurdson AJ; Schubauer-Berigan MK
Am J Ind Med; 2018 Jul; 61(7):572-581. PubMed ID: 29687925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
